Stribild is effective and well tolerated in older people with HIV
Who will PrEP be for?
Infection with HIV associated with increased risk of dialysis and end-stage kidney disease
Political leadership on finance and pace of scale-up needed to realise full potential of treatment as prevention
Tenofovir vaginal ring protects monkeys on Depo-Provera against HIV-like virus
Uptake of PrEP may be limited because few gay men think they are at risk of HIV infection
Treating HCV genotypes 2 and 3 in HIV/HCV co-infected people
Engagement: the 2013 PLWHIV Conference
